Endoscopic submucosal dissection with deliberate muscularis propria exposure for curative resection of a large type 1 gastric neuroendocrine tumor: a case report - Report - MDSpire

Endoscopic submucosal dissection with deliberate muscularis propria exposure for curative resection of a large type 1 gastric neuroendocrine tumor: a case report

  • By

  • Nana An

  • Xiuli Zheng

  • Limian Er

  • Lei Zhang

  • July 1, 2026

  • 0 min

Share

Clinical Report: Endoscopic Submucosal Dissection for Large Type 1 gNET

Background

Gastric neuroendocrine tumors (gNETs) are increasingly diagnosed, particularly type 1 gNETs associated with autoimmune gastritis. The management of larger type 1 gNETs remains controversial, with a need to balance curative intent against the invasiveness of procedures.

Data Highlights

Case study of a 48-year-old female with a 2.5 cm type 1 gNET and elevated serum gastrin (3100 pg/mL). Comprehensive staging confirmed localized, non-metastatic disease. The junctional tumor was resected en bloc using ESD-MPE, with final pathology confirming negative margins.

Key Findings

  • The patient had a 2.5 cm G2 grade type 1 gNET with elevated serum gastrin levels.
  • Comprehensive staging included endoscopic ultrasound and 68Ga-DOTATATE PET/CT, ruling out metastasis.
  • The junctional tumor was successfully resected en bloc using ESD-MPE.
  • Final pathology confirmed both lesions as pT1b, G2 NETs with negative margins.

Clinical Implications

The successful application of ESD-MPE in this case suggests that with careful patient selection and staging, endoscopic techniques can offer effective treatment for larger type 1 gNETs. This approach may reduce the need for more invasive surgical interventions.

Conclusion

This case illustrates the potential of ESD-MPE as a viable minimally invasive option for the management of larger type 1 gNETs, emphasizing the importance of precise preoperative staging.

Related Resources & Content

  1. European Neuroendocrine Tumor Society, ENETS 2023 guidance paper for gastroduodenal neuroendocrine tumors, 2023 -- Clinical guidelines
  2. Surgical Endoscopy, Greater efficiency of the double-bending method compared with conventional endoscopic submucosal dissection for the treatment of submucosal tumors of the gastric fundus, 2025
  3. Techniques in Coloproctology, Management Strategies for Giant Colorectal Lesions Exhibiting Muscle Retracting Sign (MRS+), 2025
  4. Gastric Cancer, Innovative Partial Gastrectomy Technique: Non-Exposed Endoscopic Wall-Inversion Surgery, 2013
  5. Updates in Surgery — Robotic Surgery for Submucosal Tumors of the Esophagus: A Case Series from a Single Institution
  6. https://pure.eur.nl/ws/portalfiles/portal/98662126/European_Neuroendocrine_Tumor_Society_ENETS_2023_guidance_paper_for_gastroduodenal_neuroendocrine_tumours_NETs_G1_G3.pdf
  7. Controversies in NEN: An ENETS position statement on the endoscopic management of localised gastric, duodenal and rectal neuroendocrine neoplasms

Original Source(s)

Related Content